Market Overview:
The global Balsalazide market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of ulcerative colitis, rising awareness about the benefits of Balsalazide therapy, and growing demand for generic drugs. By type, the global Balsalazide market is segmented into capsules and tablets. Capsules are expected to account for a larger share of the global Balsalazide market than tablets during the forecast period. By application, hospital is expected to account for a larger share of the global Balsalazide market than drugstore and online pharmacy during the forecast period. Geographically, North America is estimated to dominate the global Balsalazide market in 2018 followed by Europe and Asia Pacific respectively.
Product Definition:
Balsalazide is a prodrug that is converted to mesalamine in the intestine. Mesalamine reduces inflammation in the intestine by blocking the production of prostaglandins, leukotrienes, and histamines. Balsalazide is used to treat ulcerative colitis and Crohn's disease.
Capsules:
Capsules are small vesicular structures made from gelatin, which is an animal-derived collagen. They are used to administer drugs and other substances in pharmaceutical formulations. The most commonly used type of capsule is the hard gelatin capsule with a non-gelatin coating that contains phenylalanine, caffeine, and ferrous fumarate.
Tablet:
Tablet is a form of oral solid dosage drug delivery which is made up of inert materials like plastics and glass. It has the shape of a tablet, which can be divided into smaller parts with the help of scissors. The size can vary from 2 to 12 millimeters depending upon the type. They are available in different colors such as yellow, white, blue and red among others according to their usage in medicines for humans or animals by veterinary doctors or pharmacists respectively.
Application Insights:
The market is segmented by application into hospital, drugstore and online pharmacy. The drugstore application segment dominated the global market in 2017 owing to increasing usage of balsalazide tablets for the treatment of heart diseases, high blood pressure and diabetes. In addition, growing preference for this medication due to its low cost is expected to drive growth over the forecast period.
Balsalazide capsules are used in hospitals as a diuretic and anti-inflammatory agent which helps reduce edema caused due to acute kidney failure or chronic renal disease (CRC). It also acts as an effective substitute for furosemide which is used commonly as a loop diuretic. Furthermore, it reduces inflammation caused by oximeter reading above 90 mmHg thus making it suitable candidate for use in patients suffering from hypertension or cardiovascular diseases along with other associated conditions such as liver disorders or kidney stones etc.
Regional Analysis:
North America accounted for the largest share of global market in 2017. The region is expected to maintain its dominance during the forecast period owing to high product demand and presence of a large number of manufacturers. Increasing prevalence of diabetes in this region is one major factor driving balsalazide capsule sales, as capsules are recommended for treatment and control of diabetic foot ulceration.
Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 due to increasing healthcare expenditure by governments, rising awareness about diabetes care among patients, improving access & availability balsalazide tablets over counter and increasing disposable income levels especially in China & India. Moreover, growing medical tourism industry will also boost demand for these products over next few years.
Growth Factors:
- Increasing incidence of ulcerative colitis
- Rising awareness about the benefits of Balsalazide therapy
- Growing demand for effective and safe drugs for the treatment of ulcerative colitis
- Technological advancements in drug delivery systems
- Availability of generic versions of Balsalazide
Scope Of The Report
Report Attributes
Report Details
Report Title
Balsalazide Market Research Report
By Type
Capsules, Tablet
By Application
Hospital, Drugstore, Online pharmacy
By Companies
Salix Pharmaceuticals(Bausch Health), West-Ward Pharmaceuticals, Mylan, APOTEX, Par Pharmaceutical, Lupin Limited, Mysun Pharma, ANTER, Salix Pharmaceuticals(Bausch Health)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Balsalazide Market Report Segments:
The global Balsalazide market is segmented on the basis of:
Types
Capsules, Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugstore, Online pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Salix Pharmaceuticals(Bausch Health)
- West-Ward Pharmaceuticals
- Mylan
- APOTEX
- Par Pharmaceutical
- Lupin Limited
- Mysun Pharma
- ANTER
- Salix Pharmaceuticals(Bausch Health)
Highlights of The Balsalazide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Capsules
- Tablet
- By Application:
- Hospital
- Drugstore
- Online pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Balsalazide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Balsalazide is a medication used to lower blood pressure. It works by reducing the amount of fluid in the body.
Some of the key players operating in the balsalazide market are Salix Pharmaceuticals(Bausch Health), West-Ward Pharmaceuticals, Mylan, APOTEX, Par Pharmaceutical, Lupin Limited, Mysun Pharma, ANTER, Salix Pharmaceuticals(Bausch Health).
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Balsalazide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Balsalazide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Balsalazide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Balsalazide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Balsalazide Market Size & Forecast, 2020-2028
4.5.1 Balsalazide Market Size and Y-o-Y Growth
4.5.2 Balsalazide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Capsules
5.2.2 Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugstore
6.2.3 Online pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Balsalazide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Balsalazide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Capsules
9.6.2 Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugstore
9.10.3 Online pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Capsules
10.6.2 Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugstore
10.10.3 Online pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Capsules
11.6.2 Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugstore
11.10.3 Online pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Capsules
12.6.2 Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugstore
12.10.3 Online pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Capsules
13.6.2 Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugstore
13.10.3 Online pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Balsalazide Market: Competitive Dashboard
14.2 Global Balsalazide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Salix Pharmaceuticals(Bausch Health)
14.3.2 West-Ward Pharmaceuticals
14.3.3 Mylan
14.3.4 APOTEX
14.3.5 Par Pharmaceutical
14.3.6 Lupin Limited
14.3.7 Mysun Pharma
14.3.8 ANTER
14.3.9 Salix Pharmaceuticals(Bausch Health)
